Facebook, Inc.

159.2800 224.2000
52 weeks
52 weeks

Mkt Cap 504.97B

Shares Out 2.40B

Send me real-time posts from this site at my email

Cramer’s lightning round: Teladoc is worth buying

Teladoc Health: “I think Teladoc is part of the way to be able to keep costs down in health care and we’ve been behind it all the way and we’re not budging.”

Karuna Therapeutics: “Mental health is almost impossible to get right. It’s a total spec. I’m not kidding. Everybody who has tried to crack mental health has really, unfortunately, failed.”

Cloudflare: “Here’s what your nephew should do: Go over some of the stocks that we talk about a lot on the show, like a cloud king. Be in one of those. They have been vetted and vetted and vetted. I would feel so much better if he did that.”

Apellis Pharmaceuticals: “I want you to wait.”

Pinterest: “We’re kind of lukewarm. We had such high hopes and it doesn’t have the growth that we’d like. I have to tell you I prefer Twitter to it, I certainly prefer Facebook.”

Veeva Systems: “I would buy it right here. It’s one of the stocks that I think is just about poised — it’s unchanged, it’s almot unchanged for the year — to really make a move.”

Alibaba: “Oh, the only Chinese stock I’ll recommend. Why, because it’s kicking butt and I’ve got to tell you it looks a lot like an American company, except for it’s got faster sales than almost any company on earth.”

Cloudera: “It’s not as bad as it was. If that’s enough to make you want to buy their stock, it’s fine with me.”

Disclosure: Cramer’s charitable trust owns shares of Facebook.


Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer’s world? Hit him up!

- - Facebook - Instagram

Questions, comments, suggestions for the “Mad Money” website? madcap@cnbc.com


Welcome!!! Is it your First time here?

What are you looking for? Select your points of interest to improve your first-time experience:

Apply & Continue